Data / Form D filings / TAUC3 Biologics Ltd
TAUC3 Biologics Ltd: Form D filings
TAUC3 Biologics Ltd, a biotechnology company in London, United Kingdom, filed 4 Form D notices with the SEC between 2020 and 2022. The latest, on March 31, 2022, reports $690,000 sold of a $690,000 offering.
Find out what TAUC3 Biologics Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 New Street Square, Holborn, London, United Kingdom, EC4A
- Phone
- 44(0)2037433938
- Industry
- Biotechnology
- Entity type
- Other (Limited Company)
- Incorporated in
- United Kingdom
- Year incorporated
- 2019
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1830913
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | New notice | $690,000 | $690,000 | $0 | 0 | Jan 24, 2022 | sec.gov |
| Dec 28, 2020 | New notice | $18,700 | $18,700 | $0 | 1 | Dec 13, 2020 | sec.gov |
| Nov 20, 2020 | New notice | $500,000 | $11,000 | $489,000 | 2 | Oct 29, 2020 | sec.gov |
| Nov 3, 2020 | New notice | $148,500 | $148,500 | $0 | 4 | Oct 14, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Parag Saxena | Director | |
| John Gogol | Director | |
| Daniel Chain | Executive Officer, Director | |
| Andrew Heath | Director | |
| Shafique Virani | Director |
Every Form D from the week of Mar 28, 2022 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TAUC3 Biologics Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.